Practice Areas - Equity Capital Markets Law Firms and Lawyers
| Deal Date: | 28-11-2013 | Practice Area: | Equity Capital Markets |
| Deal Title: | China Pioneer Pharma Holdings HKSE IPO | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Ashurst has advised UBS and DBS in connection with the USD180 million Hong Kong initial public offering of China Pioneer Pharma Holdings Limited.
Pioneer Pharma is a leading marketing and promotion services provider for imported pharmaceutical products with a distribution network that covers over 7,500 hospitals and 40,000 drugstores in China.
UBS acted as sole global coordinator and sole sponsor in connection with the transaction, and UBS and DBS acted as joint bookrunners and joint lead managers.
The Ashurst team was led by Hong Kong partner Lina Lee, assisted by Tracy Li, Adrian Cheung and Naomi Hong. Partner Stuart Rubin led the US team, assisted by Li Jiang.
|
||
| Financial Center: | Hong Kong | Value: | 100.01-500.00 |
| Advised Party: | Lead Managers | Law Firm | Ashurst |
| Issuer Jurisdiction- | China | Listing Jurisdiction- | Hong Kong |
| Classification: |
Initial Public Offerings Hong Kong Stock Exchange |
Lawyer | Lina Lee |
